Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis
- PMID: 17347152
- DOI: 10.1074/jbc.M611259200
Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis
Abstract
When shed from the cell surface, the heparan sulfate proteoglycan syndecan-1 can facilitate the growth, angiogenesis, and metastasis of tumors. Here we report that tumor cell expression of heparanase, an enzyme known to be a potent promoter of tumor progression and metastasis, regulates both the level and location of syndecan-1 within the tumor microenvironment by enhancing its synthesis and subsequent shedding from the tumor cell surface. Heparanase regulation of syndecan-1 is detected in both human myeloma and breast cancer cell lines. This regulation requires the presence of active enzyme, because mutated forms of heparanase lacking heparan sulfate-degrading activity failed to influence syndecan-1 expression or shedding. Removal of heparan sulfate from the cell surface using bacterial heparitinase dramatically accelerated syndecan-1 shedding, suggesting that the effects of heparanase on syndecan-1 expression by tumor cells may be due, at least in part, to enzymatic removal or reduction in the size of heparan sulfate chains. Animals bearing tumors formed from cells expressing high levels of heparanase or animals transgenic for heparanase expression exhibited elevated levels of serum syndecan-1 as compared with controls, indicating that heparanase regulation of syndecan-1 expression and shedding can occur in vivo and impact cancer progression and perhaps other pathological states. These results reveal a new mechanism by which heparanase promotes an aggressive tumor phenotype and suggests that heparanase and syndecan-1 act synergistically to fine tune the tumor microenvironment and ensure robust tumor growth.
Similar articles
-
SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axis.Clin Cancer Res. 2011 Mar 15;17(6):1382-93. doi: 10.1158/1078-0432.CCR-10-2476. Epub 2011 Jan 21. Clin Cancer Res. 2011. PMID: 21257720 Free PMC article.
-
High heparanase activity in multiple myeloma is associated with elevated microvessel density.Cancer Res. 2003 Dec 15;63(24):8749-56. Cancer Res. 2003. PMID: 14695190
-
Heparanase regulates levels of syndecan-1 in the nucleus.PLoS One. 2009;4(3):e4947. doi: 10.1371/journal.pone.0004947. Epub 2009 Mar 23. PLoS One. 2009. PMID: 19305494 Free PMC article.
-
Heparanase-enhanced Shedding of Syndecan-1 and Its Role in Driving Disease Pathogenesis and Progression.J Histochem Cytochem. 2020 Dec;68(12):823-840. doi: 10.1369/0022155420937087. Epub 2020 Jul 6. J Histochem Cytochem. 2020. PMID: 32623935 Free PMC article. Review.
-
Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy.FEBS J. 2017 Jan;284(1):42-55. doi: 10.1111/febs.13932. Epub 2016 Nov 16. FEBS J. 2017. PMID: 27758044 Free PMC article. Review.
Cited by
-
Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes.J Biol Chem. 2013 Apr 5;288(14):10093-10099. doi: 10.1074/jbc.C112.444562. Epub 2013 Feb 21. J Biol Chem. 2013. PMID: 23430739 Free PMC article.
-
Dengue Virus NS1 Disrupts the Endothelial Glycocalyx, Leading to Hyperpermeability.PLoS Pathog. 2016 Jul 14;12(7):e1005738. doi: 10.1371/journal.ppat.1005738. eCollection 2016 Jul. PLoS Pathog. 2016. PMID: 27416066 Free PMC article.
-
Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments.Mol Cancer. 2023 Mar 11;22(1):48. doi: 10.1186/s12943-023-01744-8. Mol Cancer. 2023. PMID: 36906534 Free PMC article. Review.
-
Altered glycosylation in pancreatic cancer and beyond.J Exp Med. 2022 Jun 6;219(6):e20211505. doi: 10.1084/jem.20211505. Epub 2022 May 6. J Exp Med. 2022. PMID: 35522218 Free PMC article. Review.
-
Serum Syndecan-1: A Novel Biomarker for Pancreatic Ductal Adenocarcinoma.Clin Transl Gastroenterol. 2022 May 1;13(5):e00473. doi: 10.14309/ctg.0000000000000473. Clin Transl Gastroenterol. 2022. PMID: 35297817 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous